Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/13/00 → 2/28/02 |
Funding
- Glaxo Wellcome: $2,550.00
A Double-Blind, Randomized, Placebo-Controlled Surveillance Study of Asthma Event Outcomes in Subjects Receiving Either Usual Pharmacotherapy of Asthma or Usual Pharmacotherapy Plus Salmeterol 42 mcg (2 Puffs) Twice Daily
- Miller, Beth (PI)